Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

UBE2A as a prognostic indicator across human cancers: Insights from multi‑omics and immune landscape analyses

23 Jul 2026

Abstract excerpt

experiments demonstrated that UBE2A knockdown significantly suppressed breast cancer cell proliferation, migration and invasion. Overall, UBE2A was shown to be a promising prognostic biomarker associated with tumor progression, cell cycle activity and immune‑associated characteristics across cancer types. Its preferential expression in proliferative T‑cell populations and oncogenic role in breast cancer suggest...

Topics

Join the communities discussing this publication.

Cancer Immunotherapy and Biomarkers
Ferroptosis and cancer prognosis
Genetics and Neurodevelopmental Disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 42495754
DOI: 10.3892/mmr.2026.13970

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

UBE2A as a prognostic indicator across human cancers: Insights from multi‑omics and immune landscape analysesPMID 42495754Read ↗

Increased expression of UBE2T predicting poor survival of ovarian cancer: based on comprehensive analysis of UBE2s, clinical samples and the GEO databaseSemantic proximity Read ↗

Bioinformatics-based pan-cancer analysis of UBE2CSemantic proximity Read ↗

UBE2C : A pan‐cancer diagnostic and prognostic biomarker revealed through bioinformatics analysisSemantic proximity Read ↗

Increased expression of UBE2T predicting poor survival of ovarian cancer: based on bioinformatics analysis of UBE2s, clinical samples and the GEO databaseSemantic proximity Read ↗

Prognostic value of ubiquitin E2 UBE2W and its correlation with tumor-infiltrating immune cells in breast cancer.Semantic proximity Read ↗

UBE2T is a diagnostic and prognostic biomarker for endometrial cancerSemantic proximity Read ↗

Ubiquitin-conjugating enzyme 2C (UBE2C) plays as a cancer diagnostic and prognostic marker: A Bioinformatics pan-cancer analysisSemantic proximity Read ↗

A Comprehensive Bioinformatics Analysis of UBE2C in CancersSemantic proximity Read ↗

UBE2T/CDC42/CD276 signaling axis mediates brain metastasis of triple-negative breast cancer via lysosomal autophagySemantic proximity Read ↗

The Potential Impact of HNRNPA2B1 on Human Cancers Prognosis and Immune Microenvironment.Semantic proximity Read ↗

High UBE2T mRNA expression and its prognostic significance in Ovarian cancer: a study based on data miningSemantic proximity Read ↗

High UBE2T mRNA expression and its prognostic significance in Ovarian cancer: a study based on data miningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.